Explorer
Advertisement
Serum Institute
Health
Govt Panel Gives Nod To Serum Institute's qHPV Vaccine For Cervical Cancer Patients Aged 9-26 Yrs
Health
EXPLAINED: As India Clears SII's Covovax, Know What Is A Nanoparticle-Based Vaccine And How It Works
News
SII's Covovax Covid Vaccine Now Available For Children In India, Says CEO Adar Poonawalla
Health
NTAGI Approves SII's Covovax Covid-19 Vaccine For Children Between 12-17 Age Group: Report
India
'Sitting Over 200 Million Vials': Poonawalla Says Serum Institute Has Halted Production Of Covid Vaccines
India
Covovax First Indian COVID Vaccine To Be Sold In Europe, Says SII's Adar Poonawalla
India
Covishield, Covaxin Prices Revised For Private Hospitals Day Before Booster Drive Begins — Check Rates
India
SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
Health
COVID Vaccine: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults
Health
Serum Institute Seeks EUA For Its Covovax Vaccine For 12-17 Years Age Group
India
Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population
India
Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval
Videos
News
Special Report: Corona Vaccine to improve the country's economic health?
Short Videos
Advertisement
Advertisement
Advertisement
Top Headlines
Election 2024
Business
Election 2024
India
Advertisement